A Review of the New Angiotensin II‐Receptor Antagonist Irbesartan
- 1 September 1998
- journal article
- review article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 16 (3) , 169-194
- https://doi.org/10.1111/j.1527-3466.1998.tb00354.x
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Dose-Related Efficacy of Irbesartan for HypertensionHypertension, 1998
- Effects and Tolerability of Irbesartan Versus Enalapril in Patients With Severe HypertensionThe American Journal of Cardiology, 1997
- Effect of Hydrochlorothiazide on the Pharmacokinetics and Pharmacodynamics of the Angiotensin II Blocker IrbesartanClinical Drug Investigation, 1997
- Neurohumoral Mechanisms in Heart Failure: A Central Role for the Renin-Angiotensin SystemJournal of Cardiovascular Pharmacology, 1996
- Proposed Update of Angiotensin Receptor NomenclatureHypertension, 1995
- Short-term and Sustained Renal Effects of Angiotensin II Receptor Blockade in Healthy SubjectsHypertension, 1995
- Hemodynamic and Biochemical Effects of the AT 1 Receptor Antagonist Irbesartan in HypertensionHypertension, 1995
- Identification of angiotensin II receptor subtypesBiochemical and Biophysical Research Communications, 1989
- Preliminary biochemical characterization of two angiotensin II receptor subtypesBiochemical and Biophysical Research Communications, 1989
- Angiotensin converting enzyme inhibition in patients with congestive heart failure.Circulation, 1978